Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
about
[Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].Prevalence and severity of pain in cancer patients in an outpatient palliative care setting in Saudi ArabiaThe persistence of symptom burden: symptom experience and quality of life of cancer patients across one year.Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of painInformation and communication technology for managing pain in palliative care: a review of the literature.Should we cluster patients or symptoms? The myth of symptom clusters based on 'depression, insomnia, pain' and 'depression, fatigue, pain'.Palliative care needs in hospitalized cancer patients: a 5-year follow-up study.Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians.The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.The last three days of life: a comparison of pain management in the young old and the oldest old hospitalised patients using the Resident Assessment Instrument for Palliative Care.Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.Measuring individual quality of life in patients receiving radiation therapy: the SEIQoL-Questionnaire.Symptom distress profiles in hospitalized patients in Sweden: a cross-sectional study.Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014.Age-related sarcoma patient experience: results from a national survey in England
P2860
Q31104772-9809DD8E-2C9E-4ADF-BAA8-0615057A4180Q34340680-47E3D3A7-C188-4640-BE59-F89CE323B6CBQ37056412-2F696F92-EC6B-4CDC-922E-456756F16389Q37082177-72DE1BEE-BA62-4842-B1BB-794E12815661Q38197154-33E74CCC-E416-4FEF-9FAD-4231C4B82268Q40105660-8117BCFA-DC91-4989-BC98-57D8FF4BFBFFQ40126967-C1A08C3F-8E37-4E8E-9867-AF0EEA03B8FFQ44022387-DEFF1728-D5A2-4E6F-B386-7E5B5B4A2BC2Q44076205-301A4D89-9E8F-46FC-BCA4-904F11B3BC28Q44908193-9A96614E-0E34-4B41-B38E-958154676F8DQ47630042-E31D0B9F-2C0C-4E52-8033-657292505B23Q48084465-1C1F540B-4740-47D4-89CA-DD034BBE8197Q51107507-D9CEE398-435A-4E03-91C8-990906AC697FQ55093285-9343B63A-38C4-48D7-86A7-A2BC647DBD68Q58605142-7B567B89-E677-44DC-A71C-9DF8467413B9
P2860
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@en
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@nl
type
label
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@en
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@nl
prefLabel
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@en
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@nl
P2093
P2860
P356
P1476
Symptom prevalence in advanced cancer: age, gender, and performance status interactions.
@en
P2093
Aynur Aktas
Jordanka Kirkova
Lisa Rybicki
P2860
P304
P356
10.1177/1049909111410965
P50
P577
2011-06-21T00:00:00Z